FDA Inspection 1244787 — Altasciences CDMO Philadelphia, LLC

Altasciences CDMO Philadelphia, LLC — FEI 3007884119

The FDA completed an inspection of Altasciences CDMO Philadelphia, LLC on July 26, 2024 in Harleysville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Harleysville, PA (United States)